Applied DNA Sciences, Inc. (NASDAQ: APDN) Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $ ...
Below, 20 Forbes Finance Council members offer some best practices for financial firms to integrate environmental ...
By integrating advanced AI and machine learning technologies, we, just as other tech leaders can, are driving business growth ...
1d
Twisted Sifter on MSNA New Manager Came In And Demanded That All Employees Watch Hours Of Training Videos Each Month, So This Employee Got Approval To Watch Them After …When a new manager comes in to a department, they often make some changes to try to improve things. What would you do if your ...
Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...
Finance Minister Nirmala Sitharaman said that a new income tax bill will be announced next week. The bill would reflect the government’s decade-long efforts focused on enhancing taxpayer convenience.
UK households who subscribe to Netflix and Disney Plus may face an extra fee of up to £174.50 under new plans. The UK government is reportedly exploring new measures to expand the TV licence fee ...
This decision allows the NYSE Arca to list and trade shares of the new fund, which will hold both spot Bitcoin and Ether, as well as cash reserves. The SEC's approval, announced on Thursday ...
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results